Foresite Capital Management VI LLC
Q2 2026 13F-HR Holdings
Net value change ($000)
+182,305
(39.6%)
New positions
8
Sold out positions
2
Turnover %
25.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Seaport Therapeutics, Inc. | 38,651 | NEW |
| Parabilis Medicines, Inc. | 27,344 | NEW |
| ALMS | 25,953 | 27.7% |
| CLDX | 22,713 | 226.7% |
| GHRS | 20,844 | 469.9% |
| CGON | 18,009 | 12.0% |
| JBIO | 15,206 | 338.2% |
| DNLI | 12,694 | 54.6% |
| AGIO | 11,370 | 64.0% |
| BEAM | 11,326 | NEW |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|